Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Monogenic forms of lipodystrophic syndromes: diagnosis, detection, and practical management considerations from clinical cases.

Vatier C, Vantyghem MC, Storey C, Jéru I, Christin-Maitre S, Fève B, Lascols O, Beltrand J, Carel JC, Vigouroux C, Bismuth E.

Curr Med Res Opin. 2018 Nov 9:1-10. doi: 10.1080/03007995.2018.1533459. [Epub ahead of print]

PMID:
30296183
2.

MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue.

Capel E, Vatier C, Cervera P, Stojkovic T, Disse E, Cottereau AS, Auclair M, Verpont MC, Mosbah H, Gourdy P, Barraud S, Miquel A, Züchner S, Bonnefond A, Froguel P, Christin-Maitre S, Delemer B, Fève B, Laville M, Robert J, Tenenbaum F, Lascols O, Vigouroux C, Jéru I.

J Clin Lipidol. 2018 Jul 25. pii: S1933-2874(18)30310-6. doi: 10.1016/j.jacl.2018.07.009. [Epub ahead of print]

PMID:
30158064
3.

Severe Congenital Adrenal Hyperplasia Presenting as Bilateral Testicular Tumors and Azoospermia in the Third Decade of Life.

Sarfati J, Vatier C, Keller I, Guéchot J, Bellanné-Chantelot C, Christin-Maitre S.

J Endocr Soc. 2018 Jul 4;2(9):997-1000. doi: 10.1210/js.2018-00103. eCollection 2018 Sep 1.

4.

Lipodystrophic syndromes due to LMNA mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives.

Vigouroux C, Guénantin AC, Vatier C, Capel E, Le Dour C, Afonso P, Bidault G, Béréziat V, Lascols O, Capeau J, Briand N, Jéru I.

Nucleus. 2018 Jan 1;9(1):235-248. doi: 10.1080/19491034.2018.1456217.

5.

Comparison of simple indices for measuring insulin resistance that integrates adipokines in non-diabetic obese postmenopausal women before and after weight loss: A MONET study.

Vatier C, Fellahi S, Karelis AD, Brochu M, Doucet E, Prud'homme D, Rabasa-Lhoret R, Bastard JP.

Diabetes Metab. 2018 Mar;44(2):190-191. doi: 10.1016/j.diabet.2017.04.006. Epub 2017 May 23. No abstract available.

PMID:
28549774
6.

LMNA-associated partial lipodystrophy: anticipation of metabolic complications.

Jeru I, Vatier C, Vantyghem MC, Lascols O, Vigouroux C.

J Med Genet. 2017 Jun;54(6):413-416. doi: 10.1136/jmedgenet-2016-104437. Epub 2017 Apr 13.

PMID:
28408391
7.

Discovery of diabetes in the elderly: what diagnosis?

Lévy P, Pacot L, Bastard JP, Vatier C.

Ann Biol Clin (Paris). 2017 Apr 1;75(2):222-224. doi: 10.1684/abc.2017.1234.

PMID:
28377335
8.

Diabetes remission after bariatric surgery in obese patients with haemochromatosis.

Phan F, Vatier C, Vauloup-Soupault C, Poitou C, Bouillot JL, Oppert JM, Aron-Wisnewsky J.

Diabetes Metab. 2018 Mar;44(2):185-187. doi: 10.1016/j.diabet.2017.02.005. Epub 2017 Mar 14. No abstract available.

PMID:
28314670
9.

Tumor Heterogeneity Detected by 68Ga DOTATOC and 18F-FDG PET/CTs in One Malignant Insulinoma With Involvement of the Portal Splenic Confluence and Ovarian Metastases.

Bélissant Benesty O, Cassou-Mounat T, Vatier C, Talbot JN, Montravers F.

Clin Nucl Med. 2016 Nov;41(11):874-876.

PMID:
27607168
10.

One-year metreleptin therapy decreases PCSK9 serum levels in diabetic patients with monogenic lipodystrophy syndromes.

Vatier C, Arnaud L, Prieur X, Guyomarch B, Le May C, Bigot E, Pichelin M, Daguenel A, Vantyghem MC, Gautier JF, Vigouroux C, Cariou B.

Diabetes Metab. 2017 Jun;43(3):275-279. doi: 10.1016/j.diabet.2016.08.004. Epub 2016 Sep 28. No abstract available.

PMID:
27692500
11.

Bone imaging findings in genetic and acquired lipodystrophic syndromes: an imaging study of 24 cases.

Teboul-Coré S, Rey-Jouvin C, Miquel A, Vatier C, Capeau J, Robert JJ, Pham T, Lascols O, Berenbaum F, Laredo JD, Vigouroux C, Sellam J.

Skeletal Radiol. 2016 Nov;45(11):1495-506. doi: 10.1007/s00256-016-2457-9. Epub 2016 Sep 8.

PMID:
27631079
12.

Clinical Utility Gene Card for: Familial partial lipodystrophy.

Jéru I, Vatier C, Araujo-Vilar D, Vigouroux C, Lascols O.

Eur J Hum Genet. 2017 Feb;25(2). doi: 10.1038/ejhg.2016.102. Epub 2016 Aug 3. No abstract available.

13.

Clinical Utility Gene Card for: Congenital Generalized Lipodystrophy.

Jéru I, Vatier C, Araujo-Vilar D, Vigouroux C, Lascols O.

Eur J Hum Genet. 2016 Nov;24(11). doi: 10.1038/ejhg.2016.53. Epub 2016 May 18. No abstract available.

14.

Correction: A Dietary Supplement Containing Cinnamon, Chromium and Carnosine Decreases Fasting Plasma Glucose and Increases Lean Mass in Overweight or Obese Pre-Diabetic Subjects: A Randomized, Placebo-Controlled Trial.

Liu Y, Cotillard A, Vatier C, Bastard JP, Fellahi S, Stévant M, Allatif O, Langlois C, Bieuvelet S, Brochot A, Guilbot A, Clément K, Rizkalla SW.

PLoS One. 2015 Dec 14;10(12):e0145315. doi: 10.1371/journal.pone.0145315. eCollection 2015. No abstract available.

15.

Apelin: an antithrombotic factor that inhibits platelet function.

Adam F, Khatib AM, Lopez JJ, Vatier C, Turpin S, Muscat A, Soulet F, Aries A, Jardin I, Bobe R, Stepanian A, de Prost D, Dray C, Rosado JA, Valet P, Feve B, Siegfried G.

Blood. 2016 Feb 18;127(7):908-20. doi: 10.1182/blood-2014-05-578781. Epub 2015 Dec 3.

16.

One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes.

Vatier C, Fetita S, Boudou P, Tchankou C, Deville L, Riveline J, Young J, Mathivon L, Travert F, Morin D, Cahen J, Lascols O, Andreelli F, Reznik Y, Mongeois E, Madelaine I, Vantyghem M, Gautier J, Vigouroux C.

Diabetes Obes Metab. 2016 Jul;18(7):693-7. doi: 10.1111/dom.12606. Epub 2016 Jan 12.

PMID:
26584826
17.

A Dietary Supplement Containing Cinnamon, Chromium and Carnosine Decreases Fasting Plasma Glucose and Increases Lean Mass in Overweight or Obese Pre-Diabetic Subjects: A Randomized, Placebo-Controlled Trial.

Liu Y, Cotillard A, Vatier C, Bastard JP, Fellahi S, Stévant M, Allatif O, Langlois C, Bieuvelet S, Brochot A, Guilbot A, Clément K, Rizkalla SW.

PLoS One. 2015 Sep 25;10(9):e0138646. doi: 10.1371/journal.pone.0138646. eCollection 2015. Erratum in: PLoS One. 2015;10(12):e0145315.

18.

Hypoxia inhibits semicarbazide-sensitive amine oxidase activity in adipocytes.

Repessé X, Moldes M, Muscat A, Vatier C, Chetrite G, Gille T, Planes C, Filip A, Mercier N, Duranteau J, Fève B.

Mol Cell Endocrinol. 2015 Aug 15;411:58-66. doi: 10.1016/j.mce.2015.04.011. Epub 2015 Apr 20.

PMID:
25907140
19.

Nuclear envelope-related lipodystrophies.

Guénantin AC, Briand N, Bidault G, Afonso P, Béréziat V, Vatier C, Lascols O, Caron-Debarle M, Capeau J, Vigouroux C.

Semin Cell Dev Biol. 2014 May;29:148-57. doi: 10.1016/j.semcdb.2013.12.015. Epub 2013 Dec 30. Review.

PMID:
24384368
20.

What the genetics of lipodystrophy can teach us about insulin resistance and diabetes.

Vatier C, Bidault G, Briand N, Guénantin AC, Teyssières L, Lascols O, Capeau J, Vigouroux C.

Curr Diab Rep. 2013 Dec;13(6):757-67. doi: 10.1007/s11892-013-0431-7. Review.

PMID:
24026869

Supplemental Content

Loading ...
Support Center